Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for ZLDPF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
June 30, 2026 69.81M
March 31, 2026 71.13M
December 31, 2025 70.61M
September 30, 2025 70.29M
June 30, 2025 70.38M
March 31, 2025 70.69M
December 31, 2024 70.65M
September 30, 2024 70.65M
June 30, 2024 70.92M
March 31, 2024 62.30M
December 31, 2023 58.38M
September 30, 2023 58.30M
June 30, 2023 58.26M
March 31, 2023 51.77M
December 31, 2022 51.47M
September 30, 2022 46.31M
June 30, 2022 46.27M
March 31, 2022 43.22M
December 31, 2021 43.22M
September 30, 2021 43.16M
June 30, 2021 43.26M
March 31, 2021 43.16M
December 31, 2020 39.74M
September 30, 2020 39.71M
June 30, 2020 39.67M
Date Value
March 31, 2020 36.82M
December 31, 2019 35.99M
September 30, 2019 35.80M
June 30, 2019 31.75M
March 31, 2019 31.60M
December 31, 2018 30.72M
September 30, 2018 30.69M
June 30, 2018 30.69M
March 31, 2018 30.69M
December 31, 2017 30.69M
September 30, 2017 30.75M
June 30, 2017 26.19M
March 31, 2017 26.15M
December 31, 2016 25.58M
September 30, 2016 25.50M
June 30, 2016 24.53M
March 31, 2016 24.40M
December 31, 2015 23.79M
September 30, 2015 23.49M
June 30, 2015 22.95M
March 31, 2015 22.75M
December 31, 2014 22.63M
September 30, 2014 22.63M
June 30, 2014 22.63M
March 31, 2014 22.63M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Genmab A/S 597.02M
Ascendis Pharma A/S 65.67M
Bavarian Nordic A/S 227.88M
Evaxion AS 8.340M
ACADIA Pharmaceuticals, Inc. 172.13M